Key result
DES linked to roughly doubled late stent thrombosis vs. BMS in bifurcation lesions from uncovered struts.
Why the study?
Does DES compared to BMS affect neointimal growth and strut coverage at coronary bifurcation lesions in human autopsy specimens?
Population
66 human coronary bifurcation lesions from patients dying of severe coronary artery disease, sourced from…
Comparison
Drug-eluting stents (DES) vs Bare-metal stents (BMS)
Design
Cross-sectional
Authors
Loading...
DES implantation at bifurcation lesions is associated with delayed healing (uncovered struts and fibrin deposition) specifically at the flow divider, which may explain the higher prevalence of late stent thrombosis compared to BMS.
Observational (n=66)
Does DES compared to BMS affect neointimal growth and strut coverage at coronary bifurcation lesions in human autopsy specimens?
Absolute Event Rate: 75% vs 36%
DES implantation at bifurcation lesions is associated with delayed healing (uncovered struts and fibrin deposition) specifically at the flow divider, which may explain the higher prevalence of late stent thrombosis compared to BMS.
Nakazawa et al. (2010) conducted an observational in Severe coronary artery disease with bifurcation lesions (n=66). Drug-eluting stents (DES) vs. Bare-metal stents (BMS) was evaluated on Late stent thrombosis. In pathologic specimens of bifurcation lesions, late stent thrombosis was more frequent with DES (75%) than BMS (36%), associated with greater uncovered struts at flow divider sites.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: